Ephraim Resources Limited Share Price

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 10:17:55 28/02/2017 am IST 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 30.8L 27L 24.95L 22.95L 43.3L 30Cr 44L 2.98Cr 1.17Cr 15Cr 1.16Cr 1.13Cr 50Cr P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 36.28L 31.8L 29.4L 27.04L 51.01L 35Cr 51.83L 3.52Cr 1.38Cr 17Cr 1.36Cr 1.33Cr 59Cr EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 20.89L
-0.49%-4.01%-0.84%+2.28% 4.92TCr
-3.10%-1.94%+370.99%+572.60% 3.96TCr
-0.46%+2.18%+5.44%+61.01% 3.47TCr
-1.14%-1.76%+26.94%-9.93% 3.44TCr
-1.82%-1.43%+0.52%+31.85% 2.71TCr
-3.54%-5.08% - - 1.62TCr
-1.82%-0.43%+69.28%+113.82% 1.54TCr
+1.17%+2.30%+15.87%+18.26% 1.41TCr
-2.25%+0.05%+15.77%-32.83% 1.3TCr
Average +8.66%+9.23%+63.00%+94.63% 2.44TCr
Weighted average by Cap. -1.43%-1.02%+75.91%+118.68%

Financials

2017 2018
Net sales 16.01T 14.03T 12.97T 11.93T 22.51T 15.44L 22.87T 2L 60.8T 8L 60.12T 58.81T 26.03L 124 108.69 100.46 92.4 174.34 11.96T 177.13 1.2T 470.9 5.85T 465.62 455.46 20.16T
Net income -5L -4L -4L -4L -7L -4.64Cr -7L -46.59L -18.26L -2.27Cr -18.06L -17.67L -7.82Cr -10L -9L -8L -7L -13.72L -9.41Cr -13.94L -94.51L -37.05L -4.6Cr -36.63L -35.83L -16Cr
Net Debt 5L 4L 4L 4L 7L 4.79Cr 7L 48.12L 18.86L 2.34Cr 18.65L 18.25L 8.07Cr 5L 5L 4L 4L 8L 5.29Cr 8L 53.12L 20.82L 2.59Cr 20.59L 20.14L 8.91Cr
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-